Opening & registration 08:00 AM Welcome and Introduction Tânia Rodrigues (PT) | Pedro Amado (PT) | José António Pereira (PT) 08:15 AM Round Table 1 | New problems in management of liver synchronous metastases in metastatic rectal cancer Neoadjuvant therapy: how are preoperative radio and chemotherapy applied in a simultaneous approach? Teresa Macarulla (SP) Surgical options: is surgical timing important? Joan Figueras (SP) Complete response in rectal cancer with synchronous liver metastases Guilherme São Julião (BR) Managing the “vanishing” synchronous liver lesions René Adam (FR) Discussion PRELIMINARY PROGRAMME 9 MAY 2017 > AUDITORIUM 1 LEAPING FORWARD ONCOLOGY HEPATOBILIARY CANCER SESSION Opening Ceremony 12:30 PM Coffee Break 11:00 PM 08:30 AM
46
Embed
LEAPING FORWARD ONCOLOGY HEPATOBILIARY CANCER …leapingforward.hospitaldaluz.pt/media/277253/programas_total_sem... · in metastatic rectal cancer ... Update on RAPIDO trial - preoperative
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
Opening & registration08:00 AM
Welcome and IntroductionTânia Rodrigues (PT) | Pedro Amado (PT) | José António Pereira (PT)
08:15 AM
Round Table 1 | New problems in management of liver synchronous metastases in metastatic rectal cancer
Neoadjuvant therapy: how are preoperative radio and chemotherapy applied in a simultaneous approach?Teresa Macarulla (SP) Surgical options: is surgical timing important?Joan Figueras (SP)
Complete response in rectal cancer with synchronous liver metastases Guilherme São Julião (BR)
Managing the “vanishing” synchronous liver lesions René Adam (FR)
Discussion
PRELIMINARY PROGRAMME9 MAY 2017 > AUDITORIUM 1
LEAPING FORWARD ONCOLOGY HEPATOBILIARY CANCER SESSION
Opening Ceremony12:30 PM
Coffee Break11:00 PM
08:30 AM
Diagnosis and treatment of cancer patients: hail to a combination of precision and narrative medicine Manuel Sobrinho Simões (PT)
02:30 PM
Lunch01:30 PM
Round Table 2 | Intrahepatic Cholangiocarcinoma
Diagnostic imagingRichard C. Semelka (US)
Neoadjuvant treatmentTeresa Macarulla (SP)
Surgical management and the role of lymphadenectomySafi Dokmak (FR)
New procedures for the Treatment of Liver Metastases of GI Tumors - ChemosaturationFrank K. Wacker (DE)
Management of post-operative liver failureSafi Dokmak (FR)
Discussion
Closing remarksCatarina Fidalgo (PT)
06:00 PM
Director: José António Pereira | Tânia Rodrigues | Pedro Amado
Speakers: Catarina Fidalgo | Carlos Ferreira | Frank K. Wacker | Guido Torzilli | Guilherme São Julião | Joan FiguerasJosé Costa Maia | Manuel Sobrinho Simões | René Adam | Richard C. Semelka | Rui Maio | Safi Dokmak | Teresa Macarulla Thomas Aloia
Opening & registration
Welcome and IntroductionFernando Martelo (PT)
Molecular targets of lung cancer in the near futureRafael Rosell (SP)
Round Table 1 | Future of staging of lung-cancer patients
MRI in lung cancer stagingBruno Hochhegger (BR)
PET/CT or PET/MRI? Gustav von Schulthess (SW)
Video-assisted mediastinal lymphadenectomy Martin Hürtgen (DE)
Image-guided localization platform for EBUS and ultra-minimally invasive lung cancer surgeryKazuhiro Yasufuku (CA)
Coffee Break
Lunch
Opening Ceremony (Auditorium 1)
PRELIMINARY PROGRAMME 9 MAY 2017 > AUDITORIUM 2
LEAPING FORWARD ONCOLOGY LUNG CANCER SESSION
08:00 AM
08:45 AM
09:00 AM
09:45 AM
11:45 PM
11:15 PM
01:30 PM
12:30 PM
02:30 PM
03:45 PM
04:15 PM
05:10 PM
06:00 PM
Directors: Fernando Martelo | Marcos Pantarotto | Margarida Felizardo
Speakers: Bernard Park | Bruno Hochhegger | Christian Rolfo | Gustav von Schulthess | Hans Henrik Madsen | Kazuhiro Yasufuku Martin Hürtgen | Puneeth Iyengar | Rafael Rosell | Rosário Garcia Campelo
Round Table 2 | Locoregional treatment of lung cancer – future directions & controversies
Minimally invasive surgery – a place for robotic surgery? Bernard Park (US)
SBRT in cT1 and cT2: current consensus and controversiesPuneeth Iyengar (US)
RFA and MWA in early-stage-lung and metastatic disease – from promises to answersHans Henrik Madsen (DK)
Coffee Break
Round Table 3 | Metastatic non-small cell lung cancer
Target-directed treatment – our direction now Rosario Garcia Campelo (SP)
Radical treatment of the oligometastatic disease at diagnosis Puneeth Iyengar (US)
Current & future challenges in lung cancer trialsChristian Rolfo (BE)
Pro: Beyond borderline resectable? Thomas Seufferlein (DE)
Con: Selecting chemoresistant clones? Daniela Dias Santos (US) When to perform a pancreaticoduodenectomy in the absence of a positive histology Jacob Izbicki (DE)
Pancreatic carcinoma: implications of lymph nodes invasionNappo Gennaro (IT)
The future of adjuvant therapyJohn Neoptolemos (UK)
Round Table 3 | Challenges in locally advanced pancreatic cancer
Surgery for advanced pancreatic cancerMarkus W. Büchler (DE)
When, why and how is radiotherapy useful in pancreatic cancer?Florence Huguet (FR)
How to improve survival with current treatments?Margaret Tempero (US)
02:30 PM
04:30 PM Coffee break
11:45 AM
Directors: Rui Maio | Tânia Rodrigues | Pedro Marques
Speakers: Ana Faria | Andrew Rhim | Florence Huguet | Francisco Castro e Sousa | Howard Crawford | Jacob IzbickiJean Robert Delpero | John P. Neoptolemos | Laura Wood | Margaret Tempero | Markus W. Büchler | Manuel Hidalgo | Nappo Gennaro Thomas Seufferlein
State of the art in pancreatic surgery Jean Robert Delpero (FR)
05:00 PM
06:00 PM Closing remarksTânia Rodrigues (PT)
PRELIMINARY PROGRAMME10 MAY 2017 > AUDITORIUM 2
LEAPING FORWARD ONCOLOGY BREAST CANCER SESSION
Opening & registration08:15 AM
Welcome and IntroductionJosé Luís Passos Coelho (PT)
08:45 AM
Update in imaging breast cancer: MRI and PET / MRIJohannes Grueneisen (DE)
09:00 AM
Coffee Break
Round Table 1 | Hereditary breast cancer
BRCA1/2 testing or gene-panel sequencing? Gareth Evans (UK)
How to deal with variants of uncertain significance and non-BRCA mutations Diana Eccles (UK)
Management of healthy BRCA mutation carriersRita Schmutzler (DE)
Implications for treatment of BRCA-mut breast cancer Judith Balmaña (SP)
09:30 AM
11:15 AM
Round Table 2 | Issues in the locoregional treatment of early breast cancer
Towards minimal surgery in the treatment of early breast cancerMonica Morrow (US)
Tailoring RT: integrating with breast reconstruction and axillary treatment Beryl McCormick (US)
Breast reconstruction – when and for whomJaume Masia (SP)
11:45 AM
Round Table 3 | Issues in the systemic treatment of breast cancer
ER and GFR signalling Kent Osborne (US)
Residual disease after preop chemotherapy – what should we do?Nadia Harbeck (DE)
Biology of breast cancer in 2017 Carlos Caldas (UK)
02:00 PM
Directors: José Luís Passos Coelho
Speakers: Beryl McCormick | Carlos Caldas | Diana Eccles | Gareth Evans | Jaume Masia | Johannes Grueneisen | Judith BalmañaKent Osborne | Luís Costa | Mafalda Oliveira | Monica Morrow | Nadia Harbeck | Paulina Lopes | Rita Schmutzler | Robert E. Coleman
Round Table 4 | Beyond the cancer cell
Bone Health in curable breast cancerLuís Costa (PT)
Bone targeting agents as adjuvant treatment of breast cancerRobert E. Coleman (UK)
04:45 PM
Closing remarksPaulina Lopes (PT) | José Luís Passos Coelho (PT)
05:45 PM
Opening & registration08:15 AM
Welcome and IntroductionGraça André (PT) | Jorge Freitas (PT) | Dora Franco (PT) | Costa Dias (PT)
09:00 AM
PRELIMINARY PROGRAMME10 MAY 2017 > AUDITORIUM 3
LEAPING FORWARD ONCOLOGY ONCOLOGY NURSING SESSION
09:30 AM Round table 1
Oncology Nurse NavigatorMary Ann B. Case (US)
Nurse help line for cancer patientsNaomi Fitzgibbon (IE)
Role of the oncology nurse in the follow-up of cancer survivors and their families TBD
11:00 AM Coffee Break
11:30 AM Round table 2
Non-pharmacological therapies in the follow-up of cancer patientsGraça Folhas (PT)
Nursing consultation on the promotion of quality of life in patients with oncology woundHelena Vicente (PT)
Psychosocial intervention – the role of the oncology nurseCherith Semple (IE)
Director: Graça André | Marisa Falé
Faculty: Ana Santos Pereira | Cherith Semple | Costa Dias | Graça André | Graça Folhas | Helena Vicente | Margarida FaustinoMary Ann B. Case | Naomi Fitzgibbon | Sónia Caixeirinho
Closing remarksGraça André (PT)
01:00 PM
PRELIMINARY PROGRAMME10 MAY 2017 > AUDITORIUM 3
LEAPING FORWARD ONCOLOGY BODY COMPOSITION AND NUTRITION
04:00 PM
04:30 PM
05:30 PM
Round Table | The relevance of body composition in cancer patients
Imaging methods to assess body composition: a new era of nutritional assessment and intervention Carla Prado (CA)
Body composition in GI cancer patients: a prospective studySónia Velho (PT)
Body composition as a determinant of pharmacokinetics and toxicity Carla Prado (CA)
Coffee Break
Hands-on Session | Body composition analysis with computerized axial tomography imagesSónia Velho (PT) | Lisa Agostinho (PT) | Rita Cruz (PT)
Sarcopenic obesity and surgical outcome in cancer patients Carla Prado (CA)
02:30 PM
02:00 PM Welcome and IntroductionMarília Cravo (PT) | Sónia Velho (PT) | Rui Maio (PT)
Opening & registration01:45 PM
Directors: Marília Cravo | Sónia Velho | Rui Maio
Faculty: Carla Prado | Lisa Agostinho | Rita Cruz
06:30 PM Closing remarksMarília Cravo (PT)
Opening & registration08:00 AM
Discussion
Welcome and IntroductionSusana Ourô (PT) | Paulo Roquete (PT) | Catarina Fidalgo (PT)
Round Table 1 | General
08:15 AM
Molecular markers in colorectal cancer: miRNAs and its clinical implicationsCecília Rodrigues (PT)
Cancer family syndromes: polyposis registrySue Clark (UK)
New prognostic factors in colorectal oncological surgeryPhilip Quircke (UK)
08:30 AM
Round Table 2 | Colon cancer
The importance of the complete mesocolic excision (CME)Werner Hohenberger (DE)
Predicting middle colic vasculature and CME techniqueRobin Kennedy (UK)
Function after intersphincteric resection: how far can we go?Quentin Denost (FR)
10:00 AM
PRELIMINARY PROGRAMME11 MAY 2017 > AUDITORIUM 1
LEAPING FORWARD ONCOLOGY COLORECTAL CANCER SESSION
Discussion
Lunch01:30 PM
Round Table 3 | Rectal cancer I: staging, neoadjuvant therapy and decision making
MRI guided decisions and MRI/pathology quality control in rectal cancer Svetlana Balyasnikova (UK) Update on RAPIDO trial - preoperative induction therapyCornelis van de Velde (NL)
Predicting complete response: is there a role for non-operative management of rectal cancer?Karyn A. Goodman (US)
Local excision after chemo radiotherapy: danger or caution? Susana Ourô (PT)
Discussion
12:00 PM
Round Table 4 | Rectal cancer II: minimally invasive surgery
Transanal endoscopic surgery: indications for TEM, TAMIS, TEOSam Atallah (US)
TaTME: indications, surgical technique and pitfallsJoep Knol (BE)
TaTME: current evidence and functional resultsRoel Hompes (UK)
Robotic TME versus laparoscopic TMESeon Kim (KR)
02:30 PM
Coffee Break11:30 AM
Discussion
Directors: Susana Ourô | Paulo Roquete | Catarina Fidalgo
Speakers: Cecília Rodrigues | Cornelis van de Velde | Haney Youssef | Ian Jenkins | Joep Knol | Karyn A. Goodman | Quentin DenostRobin Kennedy | Roel Hompes | Philip Quircke | Sam Atallah | Sue Clark | Seon Kim | Svetlana Balyasnikova | Werner Hohenberger
Round Table 5 | Colorectal cancer: how far can we go?
Indications for ELAPE?Philip Quircke (UK)
Surgical strategies in local recurrencyIan Jenkins (UK)
Cytoreductive surgery and HIPEC in colorectal cancerHaney Youssef (UK)
Discussion
04:30 AM
Coffee Break04:00 PM
Closing remarksSusana Ourô (PT)
06:00 PM
08:15 AM
09:00 AM
09:15 AM
10:00 AM
11:30 AM
12:00 PM
Opening & registration
Welcome and IntroductionMónica Nave (PT)
Ovarian cancer pathology: new emerging conceptsJaime Prat (SP)
Round table 1 | Ovarian cancer
Intraperitoneal chemotherapy: integration of clinical trial data in clinical practiceAntonio Gonzalez (SP)
DNA repair inhibitors: iPARP and beyondMansoor Raza Mirza (DK)
Surgery (and more surgery) in ovarian cancerLuis Chiva (SP)
PRELIMINARY PROGRAMME 11 MAY 2017 > AUDITORIUM 2
LEAPING FORWARD ONCOLOGY GYNECOLOGICAL CANCER SESSION
Coffee Break
Immunotherapy in gynecologic cancerThais Baert (BE)
01:00 PM
02:00 PM
02:45 PM
04:45 PM
04:15 PM
Lunch
Update in imaging in gynecologic cancer: special focus on whole body MRI and PETJohannes Grueneisen (DE)
Round table 2 | Cervical cancer
Sentinel node biopsy and lymphadenectomy in cervical cancer: current statusDavid Cibula (CZ)
Neoadjuvant and adjuvant chemotherapy in cervical cancerGiovanni Aletti (IT)
Systemic therapy in metastatic cervical cancerAna Oaknin (SP)
Round table 3 | Endometrial cancer
Para-aortic lymph node dissection in endometrial cancer: the debate still evolvesMário Leitão (US)
Update in Radiation therapy in uterine cancerAlexandra Taylor (UK)
Systemic therapy in endometrial cancerBarbara Goff (US)
Coffee Break
Director: Mónica Nave
Speakers: Alexandra Taylor | Ana Oaknin | Antonio Gonzalez | Barbara Goff | David Cibula | Giovanni Aletti | Gustavo Mendinhos Jaime Prat | Johannes Grueneisen | Luis Chiva | Mansoor Raza Mirza | Mario Leitão | Thais Baert
From hepatic resection to hepatic transplantAndreas Pascher (DE)
Discussion
02:30 PM
Round Table 4 | Systemic therapy for NET metastasis
Targeted therapies vs chemotherapy - what's new?Jaume Capdevila (SP)
04:30 PM
Lunch01:30 PM
Coffee Break04:00 PM
Pulmonary NET and GEP NET - a different approach? Kjell Öberg (SE)
Discussion
20 years of THERANOSTICS experience in neuroendocrine tumors - past, present and future of peptide receptor radionuclide therapy (PRRT)Richard Baum (DE)
Speakers: Ana Catarino | Andreas Pascher | Belarmino Gonçalves | Francesco Panzuto | Jaume Capdevila John Ramage | Jorge Barriuso | Kjell Öberg | Macarena Rodriguez-Fraile | Richard Baum | Tim Meyer | Ulrich Peter Knigge
PRELIMINARY PROGRAMME12 MAY 2017 > AUDITORIUM 2
LEAPING FORWARD ONCOLOGY UROLOGICAL CANCER SESSION
Opening & registration08:00 AM
Welcome and IntroductionKris Maes (PT) | Francisco Mascarenhas (PT)
08:15 AM
PROSTATE CANCER
Round Table 1 | Image-guided diagnosis and treatment in prostate cancer
For how much longer will we be using the Gleason score? New kids on the blockFernando Algaba Arrea (SP)
Impact of MRI MP and MRI-targeted biopsies in diagnosis of prostate cancer Geert Villeirs (BE)
Role of MRI in staging and management of advanced prostate cancerNina Tunariu (UK) Discussion
08:30 AM
Round Table 2 | Controversies in treatment of low and medium risk prostate cancer: focal therapy
HIFU focal therapyEric Potiron (FR)
Radiation focal therapyFerran Guedea (SP)
09:30 AM
Round Table 3 | How does the future treatment of low risk and intermediate risk PC looks like
For the radiation oncologistPatrick Kupelian (US)
For the surgeon Steven Joniau (BE)
Debate | High risk prostate cancer: the futureLuís Campos Pinheiro (PT)
Radiation therapy Patrick Kupelian (US)
Radical prostatectomyArnulf Stenzl (DE)
Discussion
10:45 AM
11:30 AM
Coffee Break10:15 AM
Lunch 01:00 PM
12:15 PM TESTICULAR CANCER
Surgical issues in testicular cancer: a) Adjuvant RPLND for whom? b) Role of surgery for residual disease after chemotherapy Rafael Coelho (BR)
Round Table 4 | The management of recurrent prostate cancer after local treatment
Salvage prostatectomy/lymphadenectomy: when and how Steven Joniau (BE)
Salvage radiotherapy: when and how Ferran Guedea (SP)
Systemic therapy: when and how Robert Jones (UK)
02:00 PM
Round Table 5 | Future perspectives for treatment of advanced disease
Management of mCRPC: chemotherapy for hormone naïve metastatic patientsRobert Jones (UK)
The power of precision medicine: PSMA radioligand therapy (PRLT) of end-stage prostate cancer patients selected by PSMA PET/CTAviral Singh (DE) | Richard Baum (DE)
Coffee Break
03:00 PM
04:00 PM
BLADDER CANCER
Current and future treatment of NMIBC Oscar Rodriguez (SP)
Who profits from neo-adjuvant chemotherapy for MIBCFabio Schutz (BR)
Multimodal treatment of MIBC: external beam radiotherapy and robotic limited surgery plus brachytherapy for bladder cancerElzbieta van der Steen-Banasik (NL)
04:30 PM
Directors: Francisco Mascarenhas | Kris Maes
Faculty: Aviral Singh | Elzbieta van der Steen-Banasik | Eric Potiron | Fernando Algaba Arrea | Geert Villeirs | Nina Tunariu Oscar Rodriguez | Richard Baum | Robert Jones
Closing remarksTBD
06:00 PM
Discussion
Opening & registration08:30 AM
Welcome and Introduction José Luís Passos Coelho (PT) | Marcos Pantarotto (PT)
09:00 AM
PRELIMINARY PROGRAMME12 MAY 2017 > AUDITORIUM 3
LEAPING FORWARD ONCOLOGY CANCER IMMUNOLOGY AND IMMUNOTHERAPY SESSION
Coffee Break11:00 AM
What the Oncologist should know about the immune systemBruno Silva-Santos (PT)
09:15 AM
From bench to bedside – translating immunology into cancer immunotherapyBruno Silva-Santos (PT)
09:30 AM
Clinical challenges: evasion and resistance to cancer immunotherapyJuan Martin-Liberal (SP)
Director: Domingos Coiteiro | Francisco Mascarenhas | Luísa Albuquerque
Speakers: George Samandouras | Martin van den Bent | Stephanie E. Combs
Closing remarksTBD
06:30 PM
08:45 AM
09:00 AM
12:10 PM
09:40 AM
10:20 AM
11:30 AM
11:00 AM
08:15 AM
PRELIMINARY PROGRAMME13 MAY 2017 > AUDITORIUM 3
LEAPING FORWARD ONCOLOGY HEMATOLOGY SESSION
Welcome and IntroductionAntónio Medina Almeida (PT)
Novel molecular technologies for hematological malignanciesCarmo Fonseca (PT)
Closing remarksAntónio Medina Almeida (PT)
Diffuse large B cell lymphomas: new insights in molecular subtyping and next treatment paradigmMaria Gomes da Silva (PT)
Follicular lymphoma: molecular pathogenesis and the role of microenviromentJosé Cabeçadas (PT)
Mutations in myeloid neoplasms: insights into pathophysiology and novel treatment optionsAntónio Medina Almeida (PT)
Coffee Break
Directors: António Medina Almeida
Faculty: Carmo Fonseca | José Cabeçadas | Maria Gomes da Silva
Opening & registration
Welcome and IntroductionRaquel Santos (PT) | José Luís Passos Coelho (PT)
02:00 PM
Value of communication, what’s behind the words – train before you need toSara Batalha (PT) | Inês Moura (PT) Human factors approach to manage system variabilityRaquel Santos (PT)
Crisis resource managementDaniela Chaló (PT)
PRELIMINARY PROGRAMME13 MAY 2017 > AUDITORIUM 3
LEAPING FORWARD ONCOLOGY SIMULATION IN ONCOLOGY COMMUNICATION & TEAMWORK SESSION
Coffee Break04:15 PM
02:15 PM
03:30 PM
03:00 PM
Opening & registration01:45 PM
04:45 PM Demo – Healthcare teams performance in a simulated clinical environmentClinical Team (PT)